Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| PPAR alpha | 2 | 2023 | 29 | 1.090 |
Why?
|
| Retinal Diseases | 1 | 2022 | 18 | 0.880 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 91 | 0.640 |
Why?
|
| Cholesterol | 1 | 2019 | 230 | 0.620 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2013 | 40 | 0.460 |
Why?
|
| Hyaluronic Acid | 1 | 2013 | 45 | 0.450 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2013 | 71 | 0.450 |
Why?
|
| Carotid Stenosis | 1 | 2013 | 56 | 0.440 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2013 | 74 | 0.440 |
Why?
|
| Mice | 6 | 2023 | 2372 | 0.440 |
Why?
|
| Disease Models, Animal | 4 | 2022 | 981 | 0.420 |
Why?
|
| Animals | 12 | 2023 | 7302 | 0.400 |
Why?
|
| Mice, Knockout | 3 | 2023 | 425 | 0.360 |
Why?
|
| Nucleotidyltransferases | 2 | 2022 | 7 | 0.280 |
Why?
|
| DNA, Mitochondrial | 1 | 2022 | 28 | 0.220 |
Why?
|
| Retinal Degeneration | 1 | 2022 | 14 | 0.220 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2023 | 52 | 0.220 |
Why?
|
| Macular Degeneration | 1 | 2022 | 21 | 0.220 |
Why?
|
| Neovascularization, Pathologic | 1 | 2022 | 81 | 0.210 |
Why?
|
| Ischemia | 1 | 2022 | 92 | 0.210 |
Why?
|
| Spinal Cord Injuries | 1 | 2022 | 32 | 0.210 |
Why?
|
| Punctures | 2 | 2019 | 32 | 0.200 |
Why?
|
| Membrane Proteins | 1 | 2022 | 256 | 0.200 |
Why?
|
| Interleukin-9 | 1 | 2020 | 2 | 0.200 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2020 | 10 | 0.200 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2020 | 15 | 0.190 |
Why?
|
| Metal Nanoparticles | 1 | 2020 | 14 | 0.180 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 116 | 0.180 |
Why?
|
| Pericardium | 1 | 2020 | 50 | 0.180 |
Why?
|
| Immunoprecipitation | 1 | 2019 | 32 | 0.170 |
Why?
|
| Melanoma, Experimental | 1 | 2019 | 10 | 0.170 |
Why?
|
| Inflammation | 1 | 2022 | 508 | 0.170 |
Why?
|
| Flow Cytometry | 1 | 2019 | 172 | 0.170 |
Why?
|
| Amnion | 1 | 2019 | 36 | 0.170 |
Why?
|
| Immunotherapy | 1 | 2019 | 69 | 0.170 |
Why?
|
| Biocompatible Materials | 1 | 2020 | 210 | 0.160 |
Why?
|
| Blotting, Western | 1 | 2019 | 281 | 0.160 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2022 | 747 | 0.160 |
Why?
|
| Lung Neoplasms | 1 | 2022 | 384 | 0.160 |
Why?
|
| Rats | 3 | 2022 | 1604 | 0.140 |
Why?
|
| Atherosclerosis | 1 | 2021 | 700 | 0.130 |
Why?
|
| Signal Transduction | 2 | 2022 | 667 | 0.130 |
Why?
|
| Tissue Engineering | 1 | 2020 | 608 | 0.120 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 1019 | 0.120 |
Why?
|
| Cell Shape | 1 | 2013 | 26 | 0.120 |
Why?
|
| Hyperplasia | 1 | 2013 | 38 | 0.120 |
Why?
|
| Collagen Type I | 1 | 2013 | 39 | 0.110 |
Why?
|
| Cell Adhesion | 1 | 2013 | 103 | 0.110 |
Why?
|
| Carotid Arteries | 1 | 2013 | 97 | 0.110 |
Why?
|
| Recurrence | 1 | 2013 | 235 | 0.110 |
Why?
|
| Cell Movement | 1 | 2013 | 161 | 0.110 |
Why?
|
| Humans | 7 | 2023 | 29220 | 0.110 |
Why?
|
| Cells, Cultured | 1 | 2013 | 800 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 1 | 2013 | 711 | 0.100 |
Why?
|
| Cell Line, Tumor | 2 | 2022 | 681 | 0.090 |
Why?
|
| Microsomes | 1 | 2008 | 14 | 0.080 |
Why?
|
| Rabbits | 2 | 2019 | 185 | 0.080 |
Why?
|
| Time Factors | 1 | 2013 | 2003 | 0.080 |
Why?
|
| Cornea | 1 | 2023 | 15 | 0.060 |
Why?
|
| Lipofuscin | 1 | 2022 | 3 | 0.060 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2022 | 5 | 0.060 |
Why?
|
| Retinaldehyde | 1 | 2022 | 8 | 0.060 |
Why?
|
| Retinal Pigments | 1 | 2022 | 8 | 0.060 |
Why?
|
| Interferons | 1 | 2022 | 17 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2019 | 1219 | 0.060 |
Why?
|
| cis-trans-Isomerases | 1 | 2022 | 32 | 0.050 |
Why?
|
| Retinoids | 1 | 2022 | 41 | 0.050 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2022 | 60 | 0.050 |
Why?
|
| Wound Healing | 1 | 2023 | 182 | 0.050 |
Why?
|
| Mitochondria | 1 | 2023 | 174 | 0.050 |
Why?
|
| Recovery of Function | 1 | 2022 | 190 | 0.050 |
Why?
|
| Th1 Cells | 1 | 2020 | 18 | 0.050 |
Why?
|
| Spinal Cord | 1 | 2022 | 139 | 0.050 |
Why?
|
| Interferon-gamma | 1 | 2020 | 51 | 0.050 |
Why?
|
| Immunologic Memory | 1 | 2020 | 31 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 113 | 0.050 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2020 | 39 | 0.050 |
Why?
|
| Metals | 1 | 2020 | 16 | 0.050 |
Why?
|
| Nanostructures | 1 | 2020 | 16 | 0.050 |
Why?
|
| Mammals | 1 | 2020 | 9 | 0.050 |
Why?
|
| Transplantation, Heterologous | 1 | 2020 | 121 | 0.050 |
Why?
|
| Prostheses and Implants | 1 | 2020 | 41 | 0.040 |
Why?
|
| Cytokines | 1 | 2020 | 243 | 0.040 |
Why?
|
| Phenotype | 1 | 2020 | 629 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2020 | 436 | 0.040 |
Why?
|
| Needles | 1 | 2018 | 28 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2020 | 573 | 0.040 |
Why?
|
| Radiography | 1 | 2018 | 353 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2021 | 1695 | 0.040 |
Why?
|
| Male | 3 | 2021 | 17876 | 0.030 |
Why?
|
| Female | 2 | 2022 | 18241 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2008 | 59 | 0.020 |
Why?
|
| Pharmaceutical Preparations | 1 | 2008 | 29 | 0.020 |
Why?
|
| Middle Aged | 1 | 2021 | 10872 | 0.020 |
Why?
|